Tet2 Maintains Genome Stablity In Cardiac Myeloid Cells

被引：0
|
作者：
Dou, Yaling
Zhang, Yan
Hong, Tingting
Fang, Shaohai
Martin, James
Huang, Yun
机构：
来源：
CIRCULATION RESEARCH | 2023年 / 133卷
关键词：
Epigenetics. Immunology. Myocardial infarction;
D O I：
10.1161/res.133.suppl_1.P306
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AP3062
引用
收藏
页数：2
相关论文
共 50 条
  • [21] TET2 is a tumor suppressor gene targeted in myeloid disorders
    Delhommeau, F.
    Dupont, S.
    Kosmider, O.
    DellaValle, V.
    Masse, A.
    Dreyfus, F.
    Casadevall, N.
    Lacombe, C.
    Soulier, J.
    Viguie, F.
    Fontenay, M.
    Vainchenker, W.
    Bernard, O.
    LEUKEMIA RESEARCH, 2009, 33 : S88 - S88
  • [22] Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms
    Scopim-Ribeiro, Renata
    Machado-Neto, Joao Agostinho
    Campos, Paula de Melo
    Niemann, Fernanda Soares
    Lorand-Metze, Irene
    Costa, Fernando Ferreira
    Olalla Saad, Sara Teresinha
    Traina, Fabiola
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [23] Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency
    Wang, Jinhuan
    Miao, Zhaoyi
    Jiang, Yanan
    Zou, Ping
    Li, Weiming
    Tang, Xiaoqiong
    Lv, Yangyang
    Xing, Donghui
    Chen, Shi
    Yang, Fengchun
    Xu, Mingjiang
    Cao, Zeng
    Wang, Haitao
    Zhao, Zhigang
    ONCOLOGY LETTERS, 2020, 19 (06) : 3789 - 3798
  • [24] Metabolic Alterations Associated with Loss of TET2 Potentiates Inflammation in Myeloid Cells Driving Breast Cancer ProgressionMetabolic Alterations Associated with Loss of TET2 Potentiates Inflammation in Myeloid Cells Driving Breast Cancer Progression
    Tengesdal, Isak W.
    Mills, Taylor S.
    Elder, Alan
    Patel, Sweta B.
    May, Makenna
    Schleicher, Wolfang
    Marchetti, Carlo
    Lyons, Traci
    Dinarello, Charles
    Pietras, Eric Martin
    BLOOD, 2023, 142
  • [25] Characterization of MDS Harboring TET2 Mutations and/or TET2 Deletions
    Haferlach, Claudia
    Stengel, Anna
    Meggendorfer, Manja
    Kern, Wolfgang
    Haferlach, Torsten
    BLOOD, 2016, 128 (22)
  • [26] TET2: the terminator
    Bird, Lucy
    NATURE REVIEWS IMMUNOLOGY, 2015, 15 (10) : 598 - 598
  • [27] TET2: the terminator
    Lucy Bird
    Nature Reviews Immunology, 2015, 15 : 598 - 598
  • [28] PREVALENCE OF TET2 MUTATIONS IN DE NOVO ACUTE MYELOID LEUKAEMIA
    Nibourel, O.
    Kosmider, O.
    Cheok, M.
    Renneville, A.
    Philippe, N.
    Dombret, H.
    Dreyfus, F.
    Quesnel, B.
    Geffroy, S.
    Quentin, S.
    Roumier, C.
    Vainchenker, W.
    Bernard, O. A.
    Soulier, J.
    Fontenay, M.
    Preudhomme, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 107 - 107
  • [29] Functional cooperation of CEBPA and TET2 mutations in Acute Myeloid Leukemia
    Heyes, E.
    Schmidt, L.
    Eder, T.
    Volpe, G.
    Chatziathanasiou, K.
    Schmidt, C.
    Frampton, J.
    Grebien, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 40 - 40
  • [30] Molecular Characterization of TET2 in Cytogenetically Normal Acute Myeloid Leukemia
    Lee, J.
    Jun, K.
    Song, S.
    Oh, S.
    Shin, J.
    Kim, H.
    Lee, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 858 - 858
12345